Арилжаа Clene Inc. - CLNN CFD

Арилжааны нөхцөл

• Төрөл: CFD
• Спред: 0.0894
• Лонг позицын шөнийн санхүүжилтийн тохируулга: -0.02154%
• Шорт позицын нэг шөнийн санхүүжилтийн тохируулга: -0.00068%
• Шөнийн санхүүжилтийг тохируулах хугацаа: 22:00 (UTC)
• Валют: USD
• Арилжаалсан доод хэмжээ: 10
• Маржин: 5.00%
• Хөрөнгийн бирж: United States of America
• Арилжааны шимтгэл: 0%
• Баталгаат стопын шимтгэл: 1%

Гол үзүүлэлтүүд

• Өмнөх Хаах: 5.3353
• Нээх: 5.2953
• 1 жилийн өөрчлөлт: 13.5%
• Өдрийн диапазон: 5.0153 - 5.3253

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean surfaced nanotechnology (CSN) therapeutics. The company has a nanotechnology drug suspension; and engages in the development and commercialization of dietary supplements. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2 study for the treatment of stable multiple sclerosis; a Phase 2 biomarker study in Parkinson''s; and Phase 2 and Phase 3 trials to investigate the potential for disease modification for neurodegenerative diseases. The company''s products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat disease-causing infections, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. Clene Inc. is headquartered in Salt Lake City, Utah.